[Legofer--a new approach in the treatment of iron deficiency. Pharmacological and biopharmacological characteristics of legofer (ferric protein succinylate)].
出版信息
Akush Ginekol (Sofiia). 2002;41 Suppl 1:21-3.
PMID:12412350
Abstract
摘要
相似文献
1
[Legofer--a new approach in the treatment of iron deficiency. Pharmacological and biopharmacological characteristics of legofer (ferric protein succinylate)].
Akush Ginekol (Sofiia). 2002;41 Suppl 1:21-3.
2
[Iron protein-succinylate in the treatment of adult iron-deficiency anemia].
An Med Interna. 2002 Dec;19(12):651-2.
3
Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children.
Int J Clin Pharmacol Ther. 1998 Jun;36(6):320-5.
4
Efficacy and tolerability of oral iron protein succinylate: a systematic review of three decades of research.
Curr Med Res Opin. 2020 Apr;36(4):613-623. doi: 10.1080/03007995.2020.1716702. Epub 2020 Jan 24.
5
[The efficacy and tolerability of ferroproteinsuccinylate in iron deficiency].
Boll Chim Farm. 1988 Mar;127(3):44S-49S.
6
[The activity and tolerability of ferroproteinsuccinylate in the treatment of iron deficiency in surgery].
Boll Chim Farm. 1988 Mar;127(3):40S-43S.
7
Meta-analysis of efficacy and tolerability data on iron proteinsuccinylate in patients with iron deficiency anemia of different severity.
Arzneimittelforschung. 1995 Nov;45(11):1211-6.
8
Iron protein succynilate in the treatment of iron deficiency: potential interaction with H2-receptor antagonists.
Int J Clin Pharmacol Ther Toxicol. 1993 May;31(5):209-17.
9
Iron protein succinylate: preclinical safety assessment.
Int J Clin Pharmacol Ther Toxicol. 1993 Feb;31(2):53-60.
10
The efficacy and tolerability of iron protein succinylate in the treatment of iron-deficiency anemia in pregnancy.
Clin Exp Obstet Gynecol. 2005;32(2):117-22.
Zotero 插件